thirty previously untreated patients with carcinoma of the prostate were prospectively randomised to one of the following treatments : ethinyl oestradiol ( etivex ) combined with polyoestradiol phosphate ( estradurin ) ;
C0071554
polyoestradiol phosphate
C0687716
estradurin